GlassScriptPhysician profile
Han-Chih Chang
NPI 1790776755
$66,043.38
in general payments reported to CMS, 2019-2025
13 companies · $30K in 2025
The $30K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $24.71 · 2021: $46.92 · 2022: $2,487 · 2023: $17K · 2024: $16K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $32K · Consulting Fee: $24K · Food and Beverage: $4,028 · Travel and Lodging: $3,616 · Education: $68.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,850.00 |
| Consulting Fee | $23,700.00 |
| Food and Beverage | $4,028.33 |
| Travel and Lodging | $3,615.54 |
| Education | $68.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $30,389.19 | 2023-2025 | Barrigel, Urolift |
| Palette Life Sciences, INC. | $17,501.67 | 2022-2023 | |
| Bioprotect Medical, INC. | $15,081.03 | 2024-2025 | Bioprotect Balloon Implant System |
| Ion Beam Applications S.A. | $1,029.63 | 2019-2022 | |
| Boston Scientific Corporation | $1,028.81 | 2019-2025 | Spaceoar Vue System - 10ml |
| Icotec Medical INC. | $332.79 | 2024-2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm |
| Visionrt, INC. | $225.62 | 2024 | |
| Bard Peripheral Vascular, INC. | $152.60 | 2022-2023 | Model 200 Theraseed Palladium-103 In Readylink |
| Sumitomo Pharma America, INC. | $114.79 | 2023-2024 | Orgovyx |
| Profound Medical Corp. | $95.73 | 2023 | Tulsa-Pro |
| Novocure INC. | $54.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.04 | 2024 | |
| Incyte Corporation | $18.42 | 2023 | Jakafi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han-Chih Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.